A recent paper in Nature Biotechnology by Chakma, Sammut & Agrawal (2013) investigates the state of venture capital financing in emerging markets. The authors took a closer look at the state of VC affairs in the life sciences sectors of Brazil China, India, and South Africa. I’ll highlight some of their findings and conclusions they [...]
Is lack of relevant information the major stumbling block to VC-backed investments in the life science sector in emerging markets?
05 March 2013 How effective orchestration of resources can overcome the biomedical productivity crisis and unlock an African biotech revolution! Productivity in biomedical R&D is a frequently discussed topic. Quality has been singled out as a major issue affecting productivity in the life and biomedical sciences alike; the issue is particularly rife in the technology-driven areas of [...]
‘Innovation’ is everywhere these days. When you Google ‘innovation’ you get more than 400 million results. There are more than 300.000 books that deal with ‘innovation’ available at Amazon. Whether you play in this space or you have been exposed to the concept for the very first time, you will sooner or later be in [...]
Emerging economies, such as South Africa, have a desire to become relevant players in promising new areas of economic growth. Biotechnology is one of these areas. In order to become relevant, therefore, these countries need to allocate adequate resources to innovation, failing which they will always remain on the receiving end of products and services [...]